Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 16;26(8):2319.
doi: 10.3390/molecules26082319.

The Skeletal Effects of Tanshinones: A Review

Sophia Ogechi Ekeuku  1 , Kok-Lun Pang  1 , Kok-Yong Chin  1
Affiliations

The Skeletal Effects of Tanshinones: A Review

Sophia Ogechi Ekeuku et al. Molecules. .

Abstract

Background: Osteoporosis results from excessive bone resorption and reduced bone formation, triggered by sex hormone deficiency, oxidative stress and inflammation. Tanshinones are a class of lipophilic phenanthrene compounds found in the roots of Salvia miltiorrhiza with antioxidant and anti-inflammatory activities, which contribute to its anti-osteoporosis effects. This systematic review aims to provide an overview of the skeletal beneficial effects of tanshinones.

Methods: A systematic literature search was conducted in January 2021 using Pubmed, Scopus and Web of Science from the inception of these databases. Original studies reporting the effects of tanshinones on bone through cell cultures, animal models and human clinical trials were considered.

Results: The literature search found 158 unique articles on this topic, but only 20 articles met the inclusion criteria and were included in this review. The available evidence showed that tanshinones promoted osteoblastogenesis and bone formation while reducing osteoclastogenesis and bone resorption.

Conclusions: Tanshinones modulates bone remodelling by inhibiting osteoclastogenesis and osteoblast apoptosis and stimulating osteoblastogenesis. Therefore, it might complement existing strategies to prevent bone loss.

Keywords: antioxidant; cathepsin inhibitor; osteoblast; osteoblastogenesis; osteoclast; osteoclastogenesis; tanshinones.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flowchart of the article selection process.
See this image and copyright information in PMC

References

    1. Black D.M., Rosen C.J. Postmenopausal Osteoporosis. N. Engl. J. Med. 2016;374:254–262. doi: 10.1056/NEJMcp1513724. - DOI - PubMed
    1. Eastell R., O’Neill T.W., Hofbauer L.C., Langdahl B., Reid I.R., Gold D.T., Cummings S.R. Postmenopausal osteoporosis. Nat. Rev. Dis. Prim. 2016;2:16069. doi: 10.1038/nrdp.2016.69. - DOI - PubMed
    1. Deeks E.D. Author Correction to: Denosumab: A Review in Postmenopausal Osteoporosis. Drugs Aging. 2018;35:261. doi: 10.1007/s40266-018-0535-5. - DOI - PubMed
    1. Cosman F., De Beur S.J., LeBoff M.S., Lewiecki E.M., Tanner B., Randall S., Lindsay R. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporos. Int. 2014;25:2359–2381. doi: 10.1007/s00198-014-2794-2. - DOI - PMC - PubMed
    1. Jeremiah M.P., Unwin B.K., Greenawald M.H., Casiano V.E. Diagnosis and Management of Osteoporosis. Am. Fam. Physician. 2015;92:261–268. - PubMed

Publication types

LinkOut - more resources